Abstract
The influence of various negatively charged lipids on the stability of phospholipid stabilized oil-in-water emulsions in the presence of varying concentrations of calcium chloride was examined by a measurement of the changes in the turbidity of the emulsion over time. The data were described well by the following equation: (Ai – A) = (Ai – A0) exp(—kt) where Ai is the maximum spectrophotometric absorbance achieved in the system, A is the absorbance at time t, A0 is the absorbance at the start of the experiment and k is the flocculation or coalescence rate constant. Plots of k. and Ai/A0 vs. concentration of Ca++ provided an indication of the rate and extent of emulsion flocculation/coalescence, respectively. The sodium salts of phosphatidic acid (SPA) and oleic acid (SO) increased the critical flocculation concentration of calcium while sodium phosphatidylinositol (SPI) and sodium phosphatidylserine (SPS) had no effect on the critical flocculation concentration compared to the control emulsion. The addition of all lipid salts increased the rate of flocculation compared to the control emulsion, however, emulsions containing SPI demonstrated the highest values ofk. In contrast, emulsions containing SO coalesced to the largest extent, as indicated by large values of Ai/A0. Systems containing charged phosphatides regained some stability in higher concentrations of Ca++ while those containing oleate were comparatively more unstable up to 20 mM Ca++. Based upon the results of the present studies, it appears that phosphatidic acid is the most important fraction of the anionic phosphatides in stabilizing an emulsion in the presence of calcium ion. Emulsions of equal zeta potential did not consistently demonstrate similar flocculation behavior in the presence of added electrolyte, indicating that factors other than zeta potential can influence the flocculation behavior of the emulsions. The methods used in the present study may prove useful in evaluating the stability of emulsions against flocculation or coalescence in the presence of added substances.
- Received October 21, 1989.
- Accepted February 9, 1990.
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.
Log in using your username and password
Log in through your institution
Purchase access
patientACCESS
In This Issue
Jump to section
Related Articles
Cited By...
- No citing articles found.